Uremic Encephalopathy

Uremic Encephalopathy

Definition

Uremic encephalopathy is an organic brain syndrome caused by accumulation of uremic toxins and associated metabolic abnormalities in renal failure.

It may occur with:

• Severe AKI
• Advanced CKD/kidney failure
• Acute deterioration of CKD
• Inadequate dialysis
• Missed dialysis sessions
• Dialysis-access dysfunction causing inadequate clearance

It is generally associated with severe reduction in renal function, often eGFR <15 mL/min/1.73 m², although there is no GFR, creatinine, or BUN value that defines the syndrome. 

Why does uremia affect the brain?

Uremic encephalopathy is multifactorial. It is incorrect to think of it simply as “high urea causing confusion.”

More than 100 retained solutes have been proposed as potential uremic toxins.

Important contributors include:

Uremic toxin accumulation
→ altered neurotransmission
→ neuronal dysfunction

Electrolyte/acid-base disturbances
→ altered neuronal membrane function

Endothelial dysfunction + inflammation
→ impaired cerebral vascular regulation
→ BBB dysfunction

Hormonal/metabolic abnormalities
→ additional neuronal dysfunction

What about urea?

• Urea is the most commonly measured marker of uremia, but:
• Urea itself is probably not the principal neurotoxin responsible for uremic encephalopathy.
• BUN is therefore primarily a surrogate for accumulation of numerous retained solutes.
• This explains why there is no reliable “BUN cutoff” at which encephalopathy develops. 

Other metabolic contributors

Patients with severe kidney failure frequently have abnormalities that cause or amplify encephalopathy:

Therefore, altered mental status in a patient with renal failure should never automatically be labeled uremic encephalopathy.

Uremia and PRES

Kidney failure frequently coexists with:

• Severe hypertension
• Endothelial dysfunction
• Volume overload
• Immunosuppressive medications
• Electrolyte abnormalities

Therefore PRES may coexist with or mimic uremic encephalopathy.

Suspect PRES particularly when encephalopathy is accompanied by:

• Severe hypertension
• Seizures
• Headache
• Visual disturbance
• Focal neurological abnormalities

MRI typically demonstrates vasogenic edema, classically in posterior cerebral regions.

Clinical presentation

The presentation depends strongly on the rate of deterioration of renal function.

ICU pearl

A patient with renal failure and unexplained persistent reduced consciousness should be considered for EEG, especially if there is:

• Myoclonus
• Subtle twitching
• Fluctuating consciousness
• Recent convulsive seizure
• Failure to awaken
• Concern for nonconvulsive status epilepticus

Diagnosis

Uremic encephalopathy is a clinical diagnosis

There is:

• No diagnostic BUN cutoff
• No diagnostic creatinine cutoff
• No specific EEG pattern
• No specific MRI pattern
• No biomarker that confirms the diagnosis

Thus, in many patients the diagnosis is effectively retrospective, strengthened by neurological improvement after clearance of uremic solutes. 

Diagnostic work-up in ICU

Because UE is a diagnosis of exclusion, evaluate altered consciousness systematically.

Basic laboratory evaluation

Obtain:CBC,BUN,Creatinine

• Na⁺,K⁺,Cl⁻,HCO₃⁻,Glucose
• Ca²⁺,Mg²⁺,PO₄³⁻,Liver function tests
• ABG/VBG when appropriate

Depending on context:

• Serum osmolality
• Lactate
• Ketones
• Ammonia
• Toxicology testing
• Drug levels
• Cultures
• CRP/procalcitonin where clinically relevant
• PTH in chronic CKD evaluation

Medication review is extremely important

Renally cleared drugs can accumulate in AKI/CKD and mimic “uremic encephalopathy.”

Important examples include:

• Gabapentin
• Pregabalin
• Baclofen
• Cefepime
• Acyclovir/valacyclovir
• Opioid metabolites
• Sedatives
• Lithium
• Digoxin in appropriate circumstances

Classic ICU trap

AKI + confusion + myoclonus in a patient receiving cefepime

should raise concern for cefepime neurotoxicity, not simply uremic encephalopathy.

Similarly:

CKD + baclofen + coma

→ strongly consider baclofen toxicity.

Neuroimaging

CT brain

• CT may be completely normal in UE.
• Its major role is often excluding alternative structural pathology.

MRI findings

• MRI may also be normal.
• When abnormal, patterns include:

1. Cortical/subcortical involvement

May resemble PRES.

2. Basal ganglia involvement

• Basal ganglia hyperintensities are seen.
• “Lentiform fork sign” – bright rim highlights the medial and lateral edges of the putame3. White-matter abnormalities

EEG

EEG is not diagnostic, but it is useful.

Typical findings:

• Loss/reduction of normal alpha rhythm
• Diffuse background slowing
• Increased theta activity
• Increased delta activity
• Intermittent bursts of slow waves

Severity of EEG slowing tends to correlate with severity of renal dysfunction.

These findings are characteristic of a diffuse toxic-metabolic encephalopathy, but are not specific for uremia. 

Triphasic waves

Triphasic morphology may occur in metabolic encephalopathies.

Important point:

Triphasic waves are not specific for hepatic encephalopathy.

They may occur with:

• Uremia
• Hepatic encephalopathy
• Sepsis-associated encephalopathy
• Drug toxicity
• Other metabolic encephalopathies

EEG is particularly valuable when differentiating severe metabolic encephalopathy from nonconvulsive status epilepticus.

Differential diagnosis

 Treatment

Consider empiric thiamine

Definitive treatment = Kidney replacement therapy

Uremic encephalopathy is a uremic complication requiring initiation/intensification of KRT.

Do not wait for AEIOU laboratory thresholds

Traditional dialysis indications are remembered as:

A – Acidosis

E – Electrolyte abnormalities

I – Intoxications

O – Overload

U – Uremia

Under Uremia, major indications include:

• Uremic encephalopathy
• Uremic pericarditis
• Uremic bleeding/platelet dysfunction
• Severe refractory uremic symptoms
• Progressive uremic neuropathy

Encephalopathy itself is enough to justify KRT when attributable to uremia. 

 Seizure treatment

• Treat acute seizure according to standard seizure/status protocols.
• Initiate appropriate KRT for the underlying uremic state.
• Consider EEG for persistent impaired consciousness.

Remember to adjust maintenance antiseizure medication dosing for kidney function and dialysis clearance.

Review and stop neurotoxic medications

One of the most valuable ICU interventions is medication reconciliation.

Ask:

“Is the patient receiving a renally cleared neurotoxic drug?”

Review especially:

• Cefepime
• Baclofen
• Gabapentin
• Pregabalin
• Opioids/metabolites
• Sedatives
• Acyclovir/valacyclovir
• Lithium

Dose-adjust or discontinue as appropriate.

Some drug toxicities may themselves require dialysis.

Failure to improve after dialysis

This is a critical diagnostic checkpoint.

If adequate dialysis has occurred but encephalopathy persists, reconsider:

Was this actually uremic encephalopathy?

Re-evaluate for:

• Sepsis-associated encephalopathy
• Stroke
• Intracranial hemorrhage
• PRES
• Meningitis/encephalitis
• NCSE
• Cefepime toxicity
• Baclofen toxicity
• Sedative accumulation
• Hypoxic brain injury
• Sodium disorders
• Glucose disorders
• Hypercapnia
• Hepatic encephalopathy
• Wernicke encephalopathy

Persistent unexplained encephalopathy may require:

MRI + EEG ± lumbar puncture, depending on the clinical context. 

Lumbar puncture

CSF analysis does not diagnose uremic encephalopathy.

LP is performed when an alternative diagnosis such as:

• Meningitis
• Encephalitis
• Autoimmune encephalitis

is suspected, particularly when mental status fails to improve despite correction of uremia.